High-Revenue Products Used Off-Label May Draw Scrutiny – Ex-DoJ Lawyer

Companies with high-ticket products being used off-label are more vulnerable to government enforcement actions for off-label promotional activities, according to Sonnenschein, Nath & Rosenthal partner T. Reed Stephens

More from Archive

More from Medtech Insight